Tumors cells can escape cytotoxic CD8+ T cells by preventing MHC I display of tumor antigens. It is unknown how tumors evade CD4+ T cell responses, but since many tumor cells lack MHC II expression, novel mechanisms would be required. We have investigated this issue in a model where MHC IINEG myeloma cells secrete a monoclonal Ig containing a V region L chain epitope (VL) recognized by CD4+ T cells. Infiltrating macrophages process and present the secreted tumor antigen to Th1 cells, resulting in reciprocal induction of macrophage cytotoxicity and apparent rejection of the tumor.
Despite long-term tumor protection in VL-specific T-cell-receptor-transgenic mice, we here describe that some myeloma cells persisted in a dormant state, and eventually formed expanding tumors. Escape tumor cells maintained their secretion of complete (H+L) monoclonal Ig with unchanged sequence, while secretion of surplus free L chain was severely diminished. While free L chains were efficiently processed and presented by tumor infiltrating macrophages to CD4+ T cells, complete (H+L) monoclonal Ig was not. Forced overexpression of free L chain secretion reinstated tumor rejection. These results show that tumors can escape CD4+ T cell-mediated rejection by impairing indirect presentation of tumor antigen by infiltrating macrophages. This occurs through a novel mechanism of immunoediting, in which modulation of the quaternary structure of the secreted tumor specific antigen reduces its immunogenicity.


